1832 Asset Management L.P. Abcam PLC Transaction History

1832 Asset Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$21.54 - $24.41 $24,555 - $27,827	1,140 New	1,140 $25,000
Q2 2023 Aug 11, 2023	BUY	$12.62 - $24.47 $332,827 - $645,347	26,373 Added 830.91%	29,547 $723,000
Q1 2023 May 12, 2023	SELL	$12.98 - $17.1 $5,295 - $6,976	-408 Reduced 11.39%	3,174 $42,000
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $2,227 - $2,720	160 Added 4.68%	3,582 $55,000
Q2 2022 Aug 15, 2022	BUY	$12.69 - $19.25 $20,621 - $31,281	1,625 Added 90.43%	3,422 $49,000
Q1 2022 May 16, 2022	BUY	$15.5 - $23.89 $27,853 - $42,930	1,797 New	1,797 $32,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.